Epilepsy produces chronic chemical changes induced by altered cellular structures, and acute ones produced by conditions leading into individual seizures. Here, we aim to quantify 24 molecules simultaneously at baseline and during periods of lowered seizure threshold in rats. Using serial hippocampal microdialysis collections starting two weeks after the pilocarpine-induced status epilepticus, we evaluated how this chronic epilepsy model affects molecule levels and their interactions. Then, we quantified the changes occurring when the brain moves into a pro-seizure state using a novel model of physiological ictogenesis. Compared with controls, pilocarpine animals had significantly decreased baseline levels of adenosine, homovanillic acid, and serotonin, but significantly increased levels of choline, glutamate, phenylalanine, and tyrosine.
Epilepsy produces chronic chemical changes induced by altered cellular structures, and acute ones produced by conditions leading into individual seizures. Here, we aim to quantify 24 molecules simultaneously at baseline and during periods of lowered seizure threshold in rats. Using serial hippocampal microdialysis collections starting two weeks after the pilocarpine-induced status epilepticus, we evaluated how this chronic epilepsy model affects molecule levels and their interactions. Then, we quantified the changes occurring when the brain moves into a pro-seizure state using a novel model of physiological ictogenesis. Compared with controls, pilocarpine animals had significantly decreased baseline levels of adenosine, homovanillic acid, and serotonin, but significantly increased levels of choline, glutamate, phenylalanine, and tyrosine.
Step-wise linear regression identified that choline, homovanillic acid, adenosine, and serotonin are the most important features to characterize the difference in the extracellular milieu between pilocarpine and control animals. When increasing the hippocampal seizure risk, the concentrations of normetanephrine, serine, aspartate, and 5-hydroxyindoleacetic acid were the most prominent; however, there were no specific, consistent changes prior to individual seizures.
Introduction
Understanding the mechanisms underlying epileptogenesis and ictogenesis are a primary goal of epilepsy research. Biochemical changes are integral to these processes yet have received limited attention. Investigations of focal biochemical changes are challenging since they require frequent measurements of a large number of molecules over prolonged periods. In this work, we evaluate 24 molecules simultaneously at baseline and during periods of lowered seizure threshold.
Researchers have developed techniques to measure neurotransmitter activity in vivo such as positron emission tomography, microsensors, magnetic resonance spectroscopy, and cerebral microdialysis sampling (Anderzhanova and Wotjak, 2013; Chowdhury et al., 2015; Dupont et al., 2017; van der Zeyden et al., 2008) . Cerebral microdialysis is a well-established technique used to sample the immediate vicinity of the catheter tip in order to monitor basal concentrations over a specified sampling time. In epilepsy, past clinical and experimental microdialysis studies support the notion that an imbalance between excitatory and inhibitory neurotransmission is crucial to the pathophysiology of temporal lobe epilepsy (TLE) (Cavus et al., 2016; During and Spencer, 1993; Luna-Munguia et al., 2011; Thomas et al., 2005; Wilson et al., 1996) . Past studies associated glutamate elevation with excitotoxicity (Wang and Qin, 2010), increased hippocampal cellular excitability (Pan et al., 2008) , decreased hippocampal volume, and impaired glucose metabolism (Cavus et al., 2005 (Cavus et al., , 2008 . Later technical improvements such as high-performance liquid chromatography allowed more detailed evaluation of neurotransmitters and neurometabolites. Clinckers et al. (2005) reported that glutamate alone is not enough to induce seizures within the hippocampus in the pilocarpine rat model. Others focused on monoamines as additional seizure
